Turkey is a leading destination for colon cancer treatment, with top hospitals like Memorial Şişli Hospital, Anadolu Medical Center, and Hisar Hospital Intercontinental offering advanced care. These facilities are accredited by the Joint Commission International (JCI), ensuring international healthcare standards. Anadolu Medical Center, affiliated with Johns Hopkins Medicine, is ranked among the Top 10 hospitals worldwide by the Medical Travel Quality Alliance (MTQUA), while Memorial Şişli Hospital boasts a 90% success rate in organ transplants. Hisar Hospital Intercontinental serves over 500,000 patients annually and specializes in oncology.
Innovative procedures available in Turkey include robotic-assisted surgery, laparoscopic colectomy, hyperthermic intraperitoneal chemotherapy (HIPEC), and targeted therapy. These techniques are complemented by advanced radiotherapy methods such as IMRT and SBRT. The survival rate for colon cancer in Turkey reaches approximately 65%, reflecting the effectiveness of precise diagnostics and personalized treatment plans. Turkey's combination of cutting-edge technology, skilled professionals, and affordability makes it a preferred destination for international patients seeking high-quality cancer care.